1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. INCIDENCE AND PREVALENCE OF OBESITY
3.1.2. SURGE IN GERIATRIC POPULATION
3.1.3. RISING SPORTS-RELATED INJURIES
3.1.4. GROWING INCIDENCE OF SOFT TISSUE ASSOCIATED DISEASES
3.2. KEY RESTRAINTS
3.2.1. UNFAVORABLE REIMBURSEMENT SCENARIO
3.2.2. UNCLEAR REGULATORY ENVIRONMENTS

4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON SOFT TISSUE REPAIR MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. COMPETITIVE RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE

5. MARKET BY TYPE
5.1. LAPAROSCOPIC INSTRUMENTS
5.2. TISSUE MESH
5.2.1. BIOLOGICAL MESH
5.2.1.1. ALLOGRAFT
5.2.1.2. XENOGRAFT
5.2.2. SYNTHETIC MESH
5.3. FIXATION DEVICES
5.3.1. INTERFERENCE SCREW
5.3.2. SUTURE ANCHORS

6. MARKET BY APPLICATION
6.1. ORTHOPEDIC REPAIR
6.2. HERNIA REPAIR
6.3. SKIN REPAIR
6.4. DENTAL REPAIR
6.5. DURAL REPAIR
6.6. BREAST RECONSTRUCTION
6.7. HEAD AND NECK PRODUCTS
6.8. PELVIC AND VAGINAL PROLAPSE REPAIR

7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. KEY GROWTH ENABLERS
7.1.3. KEY CHALLENGES
7.1.4. KEY PLAYERS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET SIZE & ESTIMATES
7.2.2. KEY GROWTH ENABLERS
7.2.3. KEY CHALLENGES
7.2.4. KEY PLAYERS
7.2.5. COUNTRY ANALYSIS
7.2.5.1. GERMANY
7.2.5.2. UNITED KINGDOM
7.2.5.3. FRANCE
7.2.5.4. ITALY
7.2.5.5. RUSSIA
7.2.5.6. BELGIUM
7.2.5.7. POLAND
7.2.5.8. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET SIZE & ESTIMATES
7.3.2. KEY GROWTH ENABLERS
7.3.3. KEY CHALLENGES
7.3.4. KEY PLAYERS
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. AUSTRALIA & NEW ZEALAND
7.3.5.4. INDIA
7.3.5.5. SOUTH KOREA
7.3.5.6. THAILAND
7.3.5.7. INDONESIA
7.3.5.8. VIETNAM
7.3.5.9. REST OF ASIA-PACIFIC
7.4. REST OF WORLD
7.4.1. MARKET SIZE & ESTIMATES
7.4.2. KEY GROWTH ENABLERS
7.4.3. KEY CHALLENGES
7.4.4. KEY PLAYERS
7.4.5. REGIONAL ANALYSIS
7.4.5.1. MIDDLE EAST & AFRICA
7.4.5.2. LATIN AMERICA

8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. ALLERGAN PLC (ACQUIRED BY ABBVIE)
8.2.2. ATHERSYS INC
8.2.3. BARD PERIPHERAL VASCULAR INC (CR BARD)
8.2.4. BAXTER INTERNATIONAL INC
8.2.5. BECTON, DICKINSON AND COMPANY (BD)
8.2.6. BOSTON SCIENTIFIC CORPORATION
8.2.7. CRYOLIFE INC
8.2.8. INTEGRA LIFESCIENCES CORPORATION
8.2.9. JOHNSON & JOHNSON
8.2.10. MEDTRONIC PLC
8.2.11. ORGANOGENESIS INC
8.2.12. SMITH & NEPHEW PLC
8.2.13. STRYKER CORPORATION
8.2.14. WL GORE AND ASSOCIATES
8.2.15. ZIMMER BIOMET INC